Latest John B. Sanfilippo & Son (JBSS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest John B. Sanfilippo & Son (JBSS) Headlines

Relationships, Investing, and 1 "Real Value" Stock Pick
Adem Tahiri, The Motley Fool - Motley Fool - Mon Mar 10, 1:50PM CDT
What do relationships and investing have in common? They both tend to go sour when you over-think them.  Image courtesy of Dr. Phil Don't worry, I'm not going to go "Dr. Phil" on you. But investing is really best when it's thought of as a...

Fisher Nuts Earns American Heart Association® Certification for Nine Products
PR Newswire - Wed Feb 05, 10:27AM CST
Fisher® Nuts announced today that the American Heart Association has certified nine of its products as heart-healthy. After completing the certification process, the Heart-Check mark will be appearing on select packages of Fisher® Nuts Pecans, Walnuts and Almonds signifying that the products meet the American Heart Association's requirements to be certified as a heart-healthy food.*

John B. Sanfilippo & Son, Inc. Announces Net Income for the Second Quarter of Fiscal 2014 was $9.2 million
Business Wire - Wed Jan 29, 3:10PM CST
--Net sales increased by 4.4%

Shares of JBSS Up 41.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 29, 9:45AM CST
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on October 31st, 2012 at $16.19. In approximately 15 months, John B. Sanfilippo & Son has returned 41.92% as of today's recent price of $22.97.

John B. Sanfilippo & Son, Inc. 2nd Quarter Fiscal 2014 Operating Results Conference Call
GlobeNewswire - Thu Jan 23, 3:01PM CST
John B. Sanfilippo & Son, Inc. (Nasdaq:JBSS), a major processor and distributor of snack and baking nut products, will hold its quarterly conference call to discuss second quarter fiscal 2014 operating results on Thursday, January 30, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). Second quarter results are expected to be released after the market closes on Wednesday, January 29, 2014.

John B. Sanfilippo & Son Up 45.7% Since SmarTrend Uptrend Call (JBSS)
Comtex SmarTrend(R) - Wed Jan 22, 9:16AM CST
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on October 31st, 2012 at $16.19. In approximately 15 months, John B. Sanfilippo & Son has returned 45.69% as of today's recent price of $23.58.

53.2% Return Seen to Date on SmarTrend John B. Sanfilippo & Son Call (JBSS)
Comtex SmarTrend(R) - Tue Dec 31, 9:41AM CST
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on October 31st, 2012 at $16.19. In approximately 14 months, John B. Sanfilippo & Son has returned 53.17% as of today's recent price of $24.79.

Uptrend Call Working As John B. Sanfilippo & Son Stock Rises 57.9% (JBSS)
Comtex SmarTrend(R) - Tue Dec 24, 9:13AM CST
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on October 31st, 2012 at $16.19. In approximately 14 months, John B. Sanfilippo & Son has returned 57.86% as of today's recent price of $25.55.

Fisher Nuts and Iron Chef Alex Guarnaschelli Announce "My Fresh Twist" Recipe Contest Winner
PR Newswire - Fri Dec 20, 2:18PM CST
Nuts from more than 700 recipe submissions were chopped, diced and halved with a clear winner rising to the top. Fisher® Nuts and Iron Chef Alex Guarnaschelli have announced the winner of the first-ever "My Fresh Twist" Recipe contest - a Walnut-Bleu Date Vinaigrette Salad, submitted by Lori McLain from Denton, Texas.

Fisher Nuts Donates 200,000 Meals to Help Fight Hunger in Texas this Holiday Season
PR Newswire - Fri Dec 20, 7:00AM CST
For the second consecutive year, Fisher® Nuts donated 200,000 meals through a $20,000 donation to the San Antonio Food Bank and the Texas Food Bank Network (TFBN). More than 35 local employees from the Fisher plant in Selma, Texas joined TFBN volunteers for a check presentation ceremony and spent the morning volunteering their time and packing up holiday meals for families in need as part of the Fisher "Shares & Cares" Campaign.

John B. Sanfilippo & Son Up 50.0% Since SmarTrend Uptrend Call (JBSS)
Comtex SmarTrend(R) - Mon Dec 16, 4:53PM CST
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on October 31st, 2012 at $16.19. In approximately 14 months, John B. Sanfilippo & Son has returned 50.02% as of today's recent price of $24.28.

John B. Sanfilippo & Son Shares Up 51.6% Since SmarTrend's Buy Recommendation (JBSS)
Comtex SmarTrend(R) - Mon Dec 09, 11:03AM CST
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on October 31st, 2012 at $16.19. In approximately 13 months, John B. Sanfilippo & Son has returned 51.56% as of today's recent price of $24.53.

Fisher® Nuts and Karo® Syrup Announce Year-Round Partnership
PR Newswire - Mon Nov 25, 6:00AM CST
Fisher® Nuts and Karo® Syrup announced today the second year of their strategic marketing partnership to help promote both leading brands in-store during the holiday season. The program features custom recipes featuring Fisher Nuts and Karo Syrup that offer a fresh twist on a variety of holiday and seasonal recipes.

Shares of JBSS Up 57.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 15, 4:45PM CST
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on October 31st, 2012 at $16.19. In approximately 13 months, John B. Sanfilippo & Son has returned 57.49% as of today's recent price of $25.49.

John B. Sanfilippo & Son, Inc. to Present at the Southwest IDEAS Investor Conference in Dallas November 20 & 21, 2013
Business Wire - Wed Nov 13, 3:31PM CST
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) today announced that Mike Valentine, Chief Financial Officer and Frank Pellegrino, Senior Vice President of Finance, will present at the Southwest IDEAS Investor Conference on Thursday, November 21, 2013. The conference is being held at the Sheraton Dallas Hotel by the Galleria in Dallas, Texas. John B. Sanfilippo & Son, Inc.'s presentation is scheduled to begin at 2:40 p.m. CT (3:40 p.m. ET). A live and archived webcast of the presentation may be accessed at the conference website, www.SWIDEAS.com, or in the investor relations section of the company's website: www.jbssinc.com.

Sanfilippo (John B.) & Son Inc. (JBSS) Stock Research Links

JBSS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 80

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 14

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading
HERVolution's HERV-K Antigens: A Cancer Breakthrough?

Updated Category News Views 0

Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...

Continue Reading
QFIN Faces Lawsuit Over Broken Promises and Revenue Plunge

Updated Category News Views 35

Unmasking the Hype: QFIN's Pledge and Performance Investors, gather 'round because QFIN's latest uproar ain't pretty. The folks over at Qfin Holdings have found themselves in hot water, facing a class action lawsuit for allegedly pulling the wool over investors' eyes. Between March and August 2026, they promised a rock-solid ship braving China’s regulatory storm. Turns...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 112

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Faith on Trial: La Luz del Mundo Faces Court Ruling

Updated Category News Views 21

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

Continue Reading
Corgi Insurance Eyes $100B Auto Market with New Launch

Updated Category News Views 194

Leaping Into a Booming Market Well, it looks like someone lit a fire under Corgi Insurance, and they're ready to chase bigger bones. They’ve just rolled out a product called Corgi Business Auto, signaling quite a bold move into the hefty, nearly $100 billion U.S. commercial auto insurance arena. Now, as an old hand at this game, my ears perk up whenever I see a player...

Continue Reading
Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Updated Category News Views 0

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Continue Reading
Honeywell Aerospace Posts Solid Q3, Raises Guidance

Updated Category News Views 39

Honeywell Aerospace Surprises with Strong Third Quarter In a world where numbers are often as slippery as a greased pig, Honeywell Aerospace (NASDAQ:HONA) has managed to pin down a surprisingly robust third quarter. Let’s break it down: they’ve claimed sales of a cool $4.6 billion, reflecting a 2% bump both in reported and organic revenue from the previous year, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Pyxis Oncology Focuses on Breakthrough Therapy PYX-201

Updated Category News Views 205

Pyxis Oncology Redirects Focus to Leading Therapy PYX-201 Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage biotech firm, has announced a significant shift in its strategic direction by prioritizing its lead clinical program, PYX-201. This innovative antibody-drug conjugate (ADC) is engineered to target specific components within the tumor extracellular matrix, aiming...

Continue Reading
Ecovyst's Q3 Performance and Strategic Moves for Growth

Updated Category News Views 98

Ecovyst's Third Quarter Performance and Strategic Insights Ecovyst Inc. (NYSE: ECVT), a notable provider in the chemical industry, recently revealed its financial performance for the third quarter of 2025, showcasing significant progress in its operations and strategic decisions. The company specializes in the production of virgin sulfuric acid and regeneration services,...

Continue Reading
Consumer Interest Grows for Monthly AI Home Assistant Services

Updated Category News Views 447

Consumer Willingness to Invest in AI-Driven Home Solutions Recent research into consumer preferences reveals that a significant portion of the population is ready to embrace AI-assisted smart home technology. Parks Associates' compelling study finds that between 42% and 52% of consumers are inclined to subscribe to a monthly service for an AI smart home assistant that...

Continue Reading
Tuya Smart Introduces Hey Tuya: Revolutionizing Everyday AI Assistants

Updated Category News Views 186

Tuya Smart Unveils Hey Tuya: A Game-Changer in AI Technology In a notable advancement in AI technology, Tuya Smart (NYSE: TUYA) has introduced its innovative platform called Hey Tuya. This next-generation Super AI Life Assistant is set to redefine how individuals interact with artificial intelligence in their daily lives. The initiative represents a significant leap...

Continue Reading
Innovative Food Packaging Concept Redefines Convenience

Updated Category News Views 384

New Approach to Food and Beverage Packaging In an ever-evolving world where efficiency and convenience are paramount, an inventive solution has emerged. An inventor, motivated by the challenges of transporting, preparing, and storing food, has conceptualized an improved packaging design that promises to revolutionize these everyday tasks. Why This Invention Matters This...

Continue Reading